Aura Biosciences, Inc. Class of Warrant or Right, Outstanding
Aura Biosciences, Inc. (AURA) had Class of Warrant or Right, Outstanding of 11.17 million shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-11
- 2026-06-30: Class of Warrant or Right, Outstanding 11.17M shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 7.37M shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 7.40M shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 7.40M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2026-06-30 | 11.17M shares 10-Q · filed 2026-08-11 |
| 2026-03-31 | 7.37M shares 10-Q · filed 2026-05-11 |
| 2025-12-31 | 7.40M shares 10-Q · filed 2026-08-11 |
| 2025-09-30 | 7.40M shares 10-Q · filed 2025-11-13 |
| 2025-06-30 | 7.40M shares 10-Q · filed 2025-08-13 |
| 2024-12-31 | 12.69K shares 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |